Status:
COMPLETED
Open Dialogue About Complementary Alternative Medicine
Lead Sponsor:
Vejle Hospital
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this phase III parallel-group randomized controlled trial is to assess the efficacy of open dialogue about complementary alternative medicine integrated in conventional oncology care (O...
Detailed Description
Patients randomized to the intervention group will participate in a scheduled ODC-COC with a specialist nurse, who has completed the Fellowship in Integrative Medicine at the University of Arizona. Th...
Eligibility Criteria
Inclusion
- Speaks and reads Danish
- Diagnosed with a new primary cancer or a relapse of cancer within the last 3 months
- Planned or initiated medical oncology treatment at the Department of Oncology, Vejle Hospital
- At least two months of oncology treatment is realistic based on clinical assessment
- Life expectancy of at least six months
- Informed consent
Exclusion
- Participation in other trials
Key Trial Info
Start Date :
May 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04299451
Start Date
May 11 2020
End Date
November 30 2022
Last Update
January 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vejle Hospital
Vejle, Denmark, 7100